Overexpression of cardiac calsequestrin as a novel gene-therapy approach to treat CPVT1: in silico and in vivo proves of principle

被引:0
|
作者
Santiago Castillo, D. [1 ]
Bongianino, R. [2 ]
Trancuccio, A. [3 ]
Kukavica, D. [3 ]
Tarifa, C. [1 ]
Denegri, M. [2 ]
Mazzanti, A. [3 ]
Priori, S. G. [2 ]
机构
[1] Spanish Natl Ctr Cardiovasc Res, Madrid, Spain
[2] Ist Clin Sci Maugeri IRCCS, Pavia, Italy
[3] Univ Pavia, Pavia, Italy
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页数:2
相关论文
共 4 条
  • [1] Regnase-1 overexpression as a novel gene therapy approach for pulmonary hypertension
    Remes, A.
    Kasap, P.
    Schmiedel, N.
    Hille, S.
    Matzen, A.
    Michalewski, S.
    Laban, H.
    Hecker, M.
    Frey, N.
    Korff, T.
    Frank, D.
    Mueller, O. J.
    EUROPEAN HEART JOURNAL, 2022, 43 : 3064 - 3064
  • [2] In vivo gene therapy for SCID-X1: A novel and accessible approach with no conditioning
    Humbert, O.
    Chan, F.
    Torgerson, T. R.
    Hubbard, N.
    Humphrys, D.
    Adair, J. E.
    Trobridge, G. D.
    Scharenberg, A. M.
    Felsburg, P. J.
    Rawlings, D. J.
    Kiem, H. P.
    HUMAN GENE THERAPY, 2017, 28 (12) : A46 - A46
  • [3] Overexpression of cdk inhibitor p16INK4a by adenovirus vector inhibits cardiac hypertrophy in vitro and in vivo:: a novel strategy for the gene therapy of cardiac hypertrophy
    Nozato, T
    Ito, H
    Watanabe, M
    Ono, Y
    Adachi, S
    Tanaka, H
    Hiroe, M
    Sunamori, M
    Marumo, F
    JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2001, 33 (08) : 1493 - 1504
  • [4] VY-NPC101: in vitro and in vivo validation of a novel AAV gene replacement therapy to treat Niemann-Pick disease Type C1
    Knoll, E.
    Ezell, B.
    Liu, E.
    Sayed-Zahid, A.
    Li, M.
    Patzke, H.
    Tocci, J.
    Brown, J.
    Bales, K.
    Yonutas, H. M.
    HUMAN GENE THERAPY, 2021, 32 (19-20) : A50 - A50